John Green’s new book “Everything Is Tuberculosis” hit shelves on March 18, 2025, and it did not quietly arrive. The book shot to number one on the New York Times nonfiction bestseller list. That matters. Bestseller status means thousands of people are now reading an argument that the world’s deadliest infectious disease, a curable one, persists largely because of human decisions.
Tuberculosis kills more people than any other infectious disease. The bacteria Mycobacterium tuberculosis causes it. Drugs exist that can cure it. Yet the disease remains entrenched, especially in places where healthcare access is thin and poverty runs deep. Green’s book pushes a shift in thinking. The problem is not just the bacteria. The problem is what people do, and what they fail to do.
This is a consequences story. What happens when a bestseller reframes a global killer as a failure of human choice?
First, the audience changes. A book that hits number one reaches people who do not normally read about global health. It lands in airport bookstores, on coffee tables, in suburban book clubs. Those readers may never have thought about TB beyond a vague memory of sanitariums in old novels. Now they are being told that the disease is curable and still kills. That creates pressure. Pressure on politicians. Pressure on donors. Pressure on international health agencies.
Second, the timing matters. March 2025 is not 1995. The world has been through a pandemic. People understand, at least vaguely, what airborne disease transmission means and what happens when health systems buckle. Green’s book lands into a public that is more literate about infectious disease than any generation in decades. That literacy cuts both ways. It can breed fatalism. It can also breed demand for action.
The book argues that social, economic, and environmental factors now drive TB more than the bacteria itself. That is not a gentle argument. It points fingers at housing policy, at prison conditions, at malnutrition, at healthcare rationing. If readers absorb that argument, the conversation shifts. The question stops being “How do we cure TB?” and becomes “Why do we allow conditions where TB thrives?”
Critics and reviewers greeted the book warmly. That reception amplifies its reach. Positive reviews keep the book in the news cycle. They generate interviews. They generate op-eds. Each piece of coverage pushes the same core message: this disease is curable, it still kills, and human choices are the reason.
The paradox at the heart of the book is stark. A curable disease remains the leading infectious killer. That is not a medical failure. It is a political and social one. Green’s book does not solve that paradox. But it puts it in front of a mass audience. That audience now includes people who vote, who donate, who protest, who write letters to their representatives. Whether that translates into policy change is another question. But the conversation has been forced open.
What to watch next. Watch for mentions of the book in legislative debates. Watch for foundation funding announcements that cite Green’s work. Watch for school curricula that assign the book. Watch for public health campaigns that borrow its language. A number one bestseller does not change the world by itself. But it changes what people talk about. And what people talk about, eventually, governments are forced to address.
